Celgene Profit Margins 2006-2018 | CELG

Current and historical gross, operating and net profit margins for Celgene (CELG) over the last 10 years. The current net profit margin for Celgene (CELG) as of March 31, 2018 is 20.73%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.002B $13.003B
Celgene Corporation is a global biopharmaceutical company engaged in the discovery, development and commercialization of innovative therapies for the treatment of cancer and immune-inflammatory related diseases. Their portfolio of commercial products include REVLIMID, VIDAZA, THALOMID, POMALYST/IMNOVID, ABRAXANE, OTEZLA, ISTODAX and IDHIFA. The drug candidates in their pipeline are at various stages of preclinical and clinical development. These candidates include their IMiDs compounds, which are a proprietary class of compounds that have certain immunomodulatory and other biologically important properties in addition to their leading oral anti-inflammatory agents and cellular therapies. They believe their commercial stage products and the depth of their product pipeline, provide the catalysts for future growth.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $129.635B 15.19
Gilead Sciences (GILD) United States $100.614B 10.04
Biogen (BIIB) United States $73.532B 15.38
Vertex Pharmaceuticals (VRTX) United States $45.997B 150.42
Illumina (ILMN) United States $45.128B 63.69
Regeneron Pharmaceuticals (REGN) United States $39.593B 23.51
Alexion Pharmaceuticals (ALXN) United States $30.231B 25.16
BioMarin Pharmaceutical (BMRN) United States $18.309B 0.00
Incyte (INCY) United States $14.878B 0.00
Seattle Genetics (SGEN) United States $11.147B 0.00
Alnylam Pharmaceuticals (ALNY) United States $10.803B 0.00
Sarepta Therapeutics (SRPT) United States $9.136B 0.00
Bluebird Bio (BLUE) United States $9.051B 0.00
BeiGene (BGNE) Cayman Islands $8.930B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.516B 68.69
QIAGEN (QGEN) Netherlands $8.467B 28.32
Exact Sciences (EXAS) United States $7.772B 0.00
Alkermes (ALKS) Ireland $6.864B 0.00
Exelixis (EXEL) United States $6.489B 26.34
Bio-Techne Corp (TECH) United States $5.753B 39.46
Integra LifeSciences Holdings (IART) United States $5.536B 29.72
Galapagos (GLPG) Belgium $5.131B 0.00
Ligand Pharmaceuticals (LGND) United States $4.709B 63.17
Immunomedics (IMMU) United States $4.281B 0.00
Ultragenyx Pharmaceutical (RARE) United States $4.209B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.962B 0.00
Array BioPharma (ARRY) United States $3.596B 0.00
China Biologic Products (CBPO) China $3.343B 22.08
Spark Therapeutics (ONCE) United States $3.177B 0.00
CRISPR THERAPTC (CRSP) Switzerland $3.101B 0.00
Myriad Genetics (MYGN) United States $2.984B 36.18
Amicus Therapeutics (FOLD) United States $2.968B 0.00
Medicines (MDCO) United States $2.947B 0.00
Blueprint Medicines (BPMC) United States $2.936B 0.00
Ascendis Pharma (ASND) Denmark $2.895B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.873B 0.00
ARGENX SE-ADR (ARGX) Netherlands $2.861B 0.00
Horizon Pharma Public (HZNP) Ireland $2.789B 17.07
Emergent Biosolutions (EBS) United States $2.738B 35.01
Clovis Oncology (CLVS) United States $2.550B 0.00
Halozyme Therapeutics (HALO) United States $2.486B 38.38
REGENXBIO (RGNX) United States $2.470B 57.30
Akcea Therapeutics (AKCA) United States $2.379B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.179B 0.00
Arena Pharmaceuticals (ARNA) United States $2.175B 0.00
Momenta Pharmaceuticals (MNTA) United States $2.172B 0.00
Global Blood Therapeutics (GBT) United States $2.107B 0.00
Acceleron Pharma (XLRN) United States $2.099B 0.00
Repligen (RGEN) United States $2.091B 66.47
Puma Biotechnology (PBYI) United States $2.031B 0.00
MyoKardia (MYOK) United States $2.002B 0.00
Insmed (INSM) United States $1.942B 0.00
Genomic Health (GHDX) United States $1.874B 331.00
Cambrex (CBM) United States $1.818B 16.71
Editas Medicine (EDIT) United States $1.792B 0.00
Atara Biotherapeutics (ATRA) United States $1.756B 0.00
Aimmune Therapeutics (AIMT) United States $1.702B 0.00
AnaptysBio (ANAB) United States $1.680B 0.00
IMMURON LTD (IMRN) Australia $1.628B 0.00
BIOHAVEN PHARM (BHVN) United States $1.625B 0.00
Sangamo Therapeutics (SGMO) United States $1.528B 0.00
Innoviva (INVA) United States $1.518B 11.13
Solid Biosciences (SLDB) United States $1.502B 0.00
UniQure (QURE) Netherlands $1.462B 0.00
Mirati Therapeutics (MRTX) United States $1.431B 0.00
G1 THERAPEUTICS (GTHX) United States $1.416B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.410B 0.00
Intellia Therapeutics (NTLA) United States $1.405B 0.00
Acorda Therapeutics (ACOR) United States $1.403B 0.00
Audentes Therapeutics (BOLD) United States $1.400B 0.00
Denali Therapeutics (DNLI) United States $1.368B 0.00
Myovant Sciences (MYOV) United Kingdom $1.362B 0.00
Alder BioPharmaceuticals (ALDR) United States $1.306B 0.00
Lexicon Pharmaceuticals (LXRX) United States $1.305B 0.00
Lion Biotechnologies (IOVA) United States $1.237B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.190B 0.00
Cellectis (CLLS) France $1.180B 0.00
Athenex (ATNX) United States $1.176B 0.00
Retrophin (RTRX) United States $1.144B 0.00
NeoGenomics (NEO) United States $1.120B 231.50
Intra-Cellular Therapies (ITCI) United States $1.118B 0.00
DBV Technologies (DBVT) France $1.109B 0.00
Reata Pharmaceuticals (RETA) United States $1.104B 0.00
Revance Therapeutics (RVNC) United States $1.087B 0.00
WAVE Life Sciences (WVE) Singapore $1.081B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.068B 0.00
Apellis Pharmaceuticals (APLS) United States $1.060B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.032B 0.00
Dynavax Technologies (DVAX) United States $0.940B 0.00
Coherus BioSciences (CHRS) United States $0.930B 0.00
Epizyme (EPZM) United States $0.924B 0.00
CytomX Therapeutics (CTMX) United States $0.896B 0.00
Amarin (AMRN) Ireland $0.892B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.889B 0.00
ANI Pharmaceuticals (ANIP) United States $0.836B 17.12
Sorrento Therapeutics (SRNE) United States $0.820B 0.00
Heska (HSKA) United States $0.809B 61.99
AUTOLUS THERAPT (AUTL) United Kingdom $0.809B 0.00
InflaRx (IFRX) Germany $0.792B 0.00
AC Immune SA (ACIU) Switzerland $0.790B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.782B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.774B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.764B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.747B 0.00
EIDOS THERAPEUT (EIDX) United States $0.744B 0.00
Cara Therapeutics (CARA) United States $0.710B 0.00
Abeona Therapeutics (ABEO) United States $0.698B 0.00
APTINYX INC (APTX) United States $0.686B 0.00
Kura Oncology (KURA) United States $0.664B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.660B 0.00
UROGEN PHARMA (URGN) Israel $0.656B 0.00
Viking Therapeutics (VKTX) United States $0.651B 0.00
AVROBIO INC (AVRO) United States $0.650B 0.00
Arbutus Biopharma (ABUS) Canada $0.645B 0.00
UNITY Biotechnology (UBX) $0.641B 0.00
Senesco Technologies (ELOX) United States $0.630B 0.00
Fate Therapeutics (FATE) United States $0.627B 0.00
Geron (GERN) United States $0.627B 0.00
Monster Digital (INNT) United States $0.609B 0.00
Five Prime Therapeutics (FPRX) United States $0.608B 0.00
ObsEva SA (OBSV) Switzerland $0.595B 0.00
Prothena (PRTA) Ireland $0.595B 0.00
BeyondSpring (BYSI) United States $0.583B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.577B 0.00
Merus (MRUS) Netherlands $0.573B 0.00
Mesoblast (MESO) Australia $0.544B 0.00
Arcus Biosciences (RCUS) United States $0.543B 0.00
Aduro Biotech (ADRO) United States $0.539B 0.00
Tigenix (TIG) Belgium $0.534B 0.00
Keryx Biopharmaceuticals (KERX) United States $0.529B 0.00
Anika Therapeutics (ANIK) United States $0.521B 20.65
Novavax (NVAX) United States $0.519B 0.00
Cytokineticsorporated (CYTK) United States $0.504B 0.00
Stemline Therapeutics (STML) United States $0.490B 0.00
Verastem (VSTM) United States $0.487B 0.00
Unum Therapeutics (UMRX) United States $0.482B 0.00
Zymeworks (ZYME) Canada $0.477B 0.00
Zealand Pharma (ZEAL) Denmark $0.466B 0.00
MAGENTA THERAPT (MGTA) United States $0.459B 0.00
Sinovac Biotech (SVA) China $0.450B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.444B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.434B 0.00
Evelo Biosciences (EVLO) United States $0.416B 0.00
Albireo Pharma (ALBO) United States $0.411B 0.00
Syros Pharmaceuticals (SYRS) United States $0.401B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.398B 0.00
PDL BioPharma (PDLI) United States $0.390B 3.98
Inovio Pharmaceuticals (INO) United States $0.388B 0.00
Scholar Rock Holding (SRRK) United States $0.386B 0.00
MiMedx (MDXG) United States $0.374B 16.05
Mersana Therapeutics (MRSN) United States $0.373B 0.00
MediciNova (MNOV) United States $0.362B 0.00
RA PHARMCTL INC (RARX) United States $0.361B 0.00
Seres Therapeutics (MCRB) United States $0.356B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.350B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.345B 0.00
Cellular Biomedicine (CBMG) United States $0.340B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.337B 0.00
GTx (GTXI) United States $0.336B 0.00
Kindred Biosciences (KIN) United States $0.334B 0.00
Vericel (VCEL) United States $0.334B 0.00
Clearside Biomedical (CLSD) United States $0.328B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.323B 0.00
Adverum Biotechnologies (ADVM) United States $0.321B 0.00
Vital Therapies (VTL) United States $0.318B 0.00
Kala Pharmaceuticals (KALA) United States $0.311B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.302B 0.00
Selecta Biosciences (SELB) United States $0.298B 0.00
BioTime (BTX) United States $0.296B 0.00
Synlogic (SYBX) United States $0.293B 0.00
KEZAR LIFE SCI (KZR) United States $0.289B 0.00
Axovant Sciences (AXON) United Kingdom $0.288B 0.00
MEIRAGTX HLDGS (MGTX) United States $0.286B 0.00
Athersys (ATHX) United States $0.284B 0.00
Celyad SA (CYAD) Belgium $0.283B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.283B 0.00
OVID THERAPEUTC (OVID) United States $0.271B 0.00
Kadmon Holdings (KDMN) United States $0.260B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.258B 0.00
ResTORbio (TORC) United States $0.257B 0.00
Strongbridge Biopharma (SBBP) United States $0.250B 0.00
ChromaDex (CDXC) United States $0.250B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.245B 0.00
NantKwest (NK) United States $0.243B 0.00
Cohbar (CWBR) United States $0.242B 0.00
Enzo Biochem (ENZ) United States $0.241B 0.00
Cue Biopharma (CUE) United States $0.238B 0.00
MannKind (MNKD) United States $0.238B 0.00
Allena Pharmaceuticals (ALNA) United States $0.236B 0.00
Celcuity (CELC) United States $0.229B 0.00
Agenus (AGEN) United States $0.228B 0.00
Kamada (KMDA) Israel $0.225B 18.06
ProQR Therapeutics (PRQR) Netherlands $0.225B 0.00
Signal Genetics (MGEN) United States $0.222B 0.00
Idera Pharmaceuticals (IDRA) United States $0.219B 0.00
ADMA Biologics Inc (ADMA) United States $0.212B 0.00
Mustang Bio (MBIO) United States $0.203B 0.00
Palatin Technologies (PTN) United States $0.203B 7.85
Erytech Pharma SA Sponsored ADR (ERYP) $0.197B 0.00
XOMA (XOMA) United States $0.194B 14.72
Nymox Pharmaceutical (NYMX) Canada $0.193B 0.00
Menlo Therapeutics (MNLO) United States $0.193B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.192B 0.00
TOCAGEN INC (TOCA) United States $0.190B 0.00
VBI Vaccines (VBIV) United States $0.188B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.183B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.181B 0.00
NewLink Genetics (NLNK) United States $0.180B 0.00
Krystal Biotech (KRYS) United States $0.177B 0.00
Spero Therapeutics (SPRO) United States $0.174B 0.00
BioDelivery Sciences (BDSI) United States $0.172B 0.00
BioXcel Therapeutics (BTAI) United States $0.171B 0.00
Compugen (CGEN) Israel $0.169B 0.00
Bellerophon Therapeutics (BLPH) United States $0.166B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.166B 0.00
Fortress Biotech (FBIO) United States $0.160B 0.00
Protagonist Therapeutics (PTGX) United States $0.158B 0.00
XBiotech (XBIT) United States $0.152B 0.00
Intec Pharma (NTEC) Israel $0.151B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.150B 0.00
Organovo Holdings (ONVO) United States $0.149B 0.00
Catalyst Biosciences (CBIO) United States $0.148B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.145B 0.00
Pluristem Therapeutics (PSTI) Israel $0.144B 0.00
Anavex Life Sciences (AVXL) United States $0.143B 0.00
Cidara Therapeutics (CDTX) United States $0.138B 0.00
Motif Bio Plc (MTFB) United States $0.134B 0.00
Cocrystal Pharma (COCP) United States $0.131B 0.00
Cerecor (CERC) United States $0.130B 20.65
Pfenex (PFNX) United States $0.126B 0.00
Leap Therapeutics (LPTX) United States $0.124B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.121B 0.00
PSivida (EYPT) United States $0.116B 0.00
Gemphire Therapeutics (GEMP) United States $0.114B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.113B 0.00
Aptevo Therapeutics (APVO) United States $0.112B 0.00
Tapimmune (TPIV) United States $0.111B 0.00
Trevena (TRVN) United States $0.109B 0.00
Aptose Biosciences (APTO) Canada $0.107B 0.00
Proteostasis Therapeutics (PTI) United States $0.103B 0.00
ScPharmaceuticals (SCPH) United States $0.102B 0.00
GENPREX INC (GNPX) United States $0.101B 0.00
Asterias Biotherapeutics (AST) United States $0.099B 0.00
Ophthotech (OPHT) United States $0.098B 0.67
Eleven Biotherapeutics (SESN) United States $0.097B 0.00
Sophiris Bio (SPHS) United States $0.095B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.094B 0.00
Alcobra (ARCT) Israel $0.094B 0.00
Orgenesis (ORGS) United States $0.091B 0.00
Oncolytics Biotech (ONCY) Canada $0.089B 0.00
Checkpoint Therapeutics (CKPT) United States $0.088B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.086B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.084B 0.00
VIVUS (VVUS) United States $0.082B 0.00
Axsome Therapeutics (AXSM) United States $0.081B 0.00
ENTERA BIO LTD (ENTX) Israel $0.076B 0.00
Celldex Therapeutics (CLDX) United States $0.075B 0.00
Aileron Therapeutics (ALRN) United States $0.074B 0.00
Evogene (EVGN) Israel $0.074B 0.00
Applied Genetic Technologies (AGTC) United States $0.072B 0.00
Histogenics (HSGX) United States $0.071B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.071B 0.00
Prima BioMed (IMMP) Australia $0.071B 0.00
Advaxis (ADXS) United States $0.071B 0.00
Alimera Sciences (ALIM) United States $0.070B 0.00
Novelion Therapeutics (NVLN) Canada $0.069B 0.00
Neothetics (EVFM) United States $0.068B 0.00
OncoSec Medical (ONCS) United States $0.068B 0.00
Protalix BioTherapeutics (PLX) Israel $0.065B 0.00
Vascular Biogenics (VBLT) Israel $0.064B 0.00
Eyenovia (EYEN) United States $0.064B 0.00
Curis (CRIS) United States $0.063B 0.00
VolitionRX (VNRX) Singapore $0.061B 0.00
Caladrius Biosciences (CLBS) United States $0.059B 0.00
Celsion (CLSN) United States $0.054B 0.00
Zosano Pharma (ZSAN) United States $0.052B 0.00
VTv Therapeutics (VTVT) United States $0.052B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.049B 0.00
Arsanis (ASNS) United States $0.049B 0.00
Proteon Therapeutics (PRTO) United States $0.048B 0.00
TRACON Pharmaceuticals (TCON) United States $0.047B 0.00
Moleculin Biotech (MBRX) United States $0.045B 0.00
AZURRX BIOPHARM (AZRX) United States $0.045B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.043B 0.00
CytRx (CYTR) United States $0.042B 0.00
BioPharmX (BPMX) United States $0.041B 0.00
Cellect Biotechnology (APOP) Israel $0.040B 0.00
AquaBounty Technologies (AQB) United States $0.040B 0.00
Chiasma (CHMA) United States $0.038B 0.00
Benitec Biopharma (BNTC) Australia $0.035B 0.00
OvaScience (OVAS) United States $0.034B 0.00
AEterna Zentaris (AEZS) United States $0.032B 0.00
Edge Therapeutics (EDGE) United States $0.032B 0.00
VistaGen Therapeutics (VTGN) United States $0.032B 0.00
Oncobiologics (ONS) United States $0.029B 0.00
ATyr Pharma (LIFE) United States $0.028B 0.00
Synthetic Biologics (SYN) United States $0.028B 0.00
Vical (VICL) United States $0.027B 0.00
Cleveland BioLabs (CBLI) United States $0.027B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.025B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.025B 0.00
RestorGenex (DFFN) United States $0.023B 0.00
CorMedix Inc (CRMD) United States $0.023B 0.00
Pulmatrix (PULM) United States $0.022B 0.00
Cel-Sci (CVM) United States $0.020B 0.00
Prana Biotechnology (PRAN) Australia $0.020B 0.00
Titan Pharmaceuticals (TTNP) United States $0.019B 0.00
Neuralstem (CUR) United States $0.018B 0.00
AmpliPhi Biosciences (APHB) United States $0.018B 0.00
Genetic Technologies (GENE) Australia $0.018B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.018B 0.00
Novogen (KZIA) Australia $0.016B 0.00
Flex Pharma (FLKS) United States $0.015B 0.00
Cerulean Pharma (DARE) United States $0.015B 0.00
Hemispherx BioPharma (HEB) United States $0.014B 0.00
Fibrocell Science Inc (FCSC) United States $0.014B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.012B 0.00
Therapix Biosciences (TRPX) Israel $0.011B 5.47
Galena Biopharma (SLS) United States $0.011B 0.00
Alliqua BioMedical (ALQA) United States $0.011B 0.00
ImmunoCellular Therapeutics (IMUC) United States $0.010B 0.00
Tenax Therapeutics (TENX) United States $0.010B 0.00
IBio (IBIO) United States $0.009B 0.00
MYOS RENS Technology (MYOS) United States $0.009B 0.00
Soligenix (SNGX) United States $0.009B 0.00
ARCA Biopharma (ABIO) United States $0.008B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.007B 0.00
Immune Pharmaceuticals (IMNP) United States $0.007B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Oragenics (OGEN) United States $0.005B 0.00
TrovaGene (TROV) United States $0.004B 0.00
Aytu Bioscience (AYTU) United States $0.002B 0.00